OCTP — Oxford Cannabinoid Technologies Holdings Income Statement
0.000.00%
- £1.47m
 - £0.34m
 
Annual income statement for Oxford Cannabinoid Technologies Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.
2019 May 31st  | 2020 May 31st  | 2021 May 31st  | 2022 April 30th  | 2023 April 30th  | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 11 M | 12 M | 
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 
| Cost of Revenue | |||||
| Gross Profit | — | — | -0.445 | -2.89 | -4.3 | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.77 | 2.37 | 3.37 | 5.5 | 7.04 | 
| Operating Profit | -2.77 | -2.37 | -3.37 | -5.5 | -7.04 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.88 | -2.37 | -3.37 | -5.5 | -7.03 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.62 | -2.14 | -3.23 | -4.71 | -5.95 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.62 | -2.14 | -3.23 | -4.71 | -5.95 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.62 | -2.14 | -3.23 | -4.71 | -5.95 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.003 | -0.002 | -0.004 | -0.005 | -0.006 | 
| Dividends per Share |